Moderna, Inc. company logo
Moderna, Inc. logo

Moderna, Inc. (MRNA) Cash From Financing

Annual CFF

$56.00M$1.43B+104.07%

Summary

Current Value
As of today, MRNA annual cash from financing is $56.00M, up +104.07% on
Historical Performance
MRNA annual cash from financing is up +106.41% over the past 3 years, and up +7.69% over the past 5 years
All-Time High Comparison
MRNA annual cash from financing is currently -97.25% below its historical high of $2.03B set on
3-Year Low Comparison
MRNA annual cash from financing is +101.62% above its 3-year low of -$3.45B reached on an earlier date
Sector Comparison
MRNA annual cash from financing is higher than 76.32% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

MRNA Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$56.00M+104.1%+106.4%+7.7%+1053.7%
Quarterly Cash From Financing-$1.00M-109.1%+99.9%-103.4%-1615.2%
TTM Cash From Financing$9.00M+118.0%+100.2%-99.5%-14.6%
Price$39.60+12.7%-79.4%-68.1%
Annual Cash From Operations-$3.00B+3.7%-122.1%-554.5%-10000.0%
Annual Cash From Investing$1.95B-53.7%+122.9%+10000.0%+10000.0%
Annual Dividends Paid$0.000.0%0.0%0.0%
Annual Total Debt$747.00M-39.9%-18.4%+449.5%+10000.0%
Shares Outstanding390.73M+1.2%+1.5%-2.0%

Cash From Financing Highs

MRNA Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$56.00Mat high
5Y$2.03BN/A-97.3%
All$2.03B-97.3%

Cash From Financing Lows

MRNA Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y-$3.45BN/A+101.6%
5Y-$3.45B+101.6%
All-$3.45B+101.6%

Cash From Financing History

YearValueChange
$56.00M+104.1%
-$1.38B+60.1%
-$3.45B-295.0%
-$873.00M-142.9%
$2.03B+3,809.6%
$52.00M-95.8%
$1.23B>+9,900.0%
$168.00K-100.0%
$472.91M>+9,900.0%
$1.10M-80.8%
$5.69M>+9,900.0%
-$2,000.00-100.1%
$2.57M-84.0%
$16.02M+28.4%
$12.48M+157.1%
$4.85M+176.9%
YearValueChange
$1.75M-95.7%
$41.01M+157.1%
$15.95M-46.5%
$29.79M-56.2%
$68.00M+467.8%
$11.98M+57.9%
$7.59M-41.7%
$13.02M>+9,900.0%
$44.00K+108.8%
-$500.00K-135.7%
$1.40M-92.0%
$17.60M+309.3%
$4.30M+43.3%
$3.00M0.0%
$3.00M-37.5%
$4.80M-

FAQ

  • What is the current annual cash from financing of MRNA?

    As of today, MRNA annual cash from financing is $56.00M

  • What is 1-year change in MRNA annual cash from financing?

    MRNA annual cash from financing is up +104.07% year-over-year

  • What is 3-year change in MRNA annual cash from financing?

    MRNA annual cash from financing is up +106.41% over the past 3 years

  • How far is MRNA annual cash from financing from its all-time high?

    MRNA annual cash from financing is currently -97.25% below its historical high of $2.03B set on December 31, 2020

  • How does MRNA annual cash from financing rank versus sector peers?

    MRNA annual cash from financing is higher than 76.32% of companies in Healthcare sector

  • When is MRNA next annual earnings release?

    The next annual earnings release for MRNA is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. MRNA Official Website www.modernatx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1682852/000168285225000075/0001682852-25-000075-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1682852/000168285225000022/0001682852-25-000022-index.htm
  4. MRNA Profile on Yahoo Finance finance.yahoo.com/quote/MRNA
  5. MRNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mrna